Subscribe to be notified for updates: RSS Feed


Featured Video
CEO, Bruno Jactel Discusses Vamousse And The Group’s Very Good First Half
News Highlights

Operational and financial highlights for the first half of 2016 with commentary from Chairman of the Board, Jose Barella, and CEO, Bruno Jactel. Read more…

The Company’s trading performance in the first half continues the upward trend from prior periods. Unit sales of Vamousse were in line with expectations. The roll-out of PureScience in the first half was slower than anticipated mainly due to the time of completing the field trials. Read more

Announcing the final results for the year ending 31 December 2015, including comments from the Chairman and CEO. Read more

Announcing a number of new initiatives including expansion into the European market; the launch of a new product to complement the Vamousse range; and further distribution expansion in both the US and the UK.. Read more